Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter van Dam

Showing results (111-120 of 112) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 112 results.
Frontiers in Immunology|January 9, 2023
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factorsAngelina Konnova, Fien H R De Winter, Akshita Gupta, et al.
International Journal of Cancer|May 18, 2022
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trialSimone N Koole, Philip C Schouten, Jan Hauke, et al.
Pageof 12

Showing results (111-120 of 112) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 112 results.
Frontiers in Immunology|January 9, 2023
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factorsAngelina Konnova, Fien H R De Winter, Akshita Gupta, et al.
International Journal of Cancer|May 18, 2022
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trialSimone N Koole, Philip C Schouten, Jan Hauke, et al.
Pageof 12